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Conference Summary
Fifth Annual 
Conference on New 
and Re-Emerging 
Infectious Diseases 
The fifth annual Conference on
New and Re-Emerging Infectious Dis-
eases was hosted on April 18–19,
2002, by the College of Veterinary
Medicine, University of Illinois at
Urbana-Champaign (UIUC). The con-
ference featured 8 speakers and 35
poster presentations. 
Recent Infectious Diseases
Beatrice Hahn (University of Ala-
bama, Birmingham, AL) opened the
conference with a presentation on the
search for the origins of HIV. The evi-
dence indicates that two simian immu-
nodeficiency viruses (SIV), one from
chimpanzees (SIVcpz) and  the other
from sooty mangabeys (SIVsm),
crossed the species barrier to humans,
generating HIV-1 and HIV-2, respec-
tively. Dr. Hahn stressed the impor-
tance of characterizing the prevalence,
geographic distribution, and genetic
diversity of naturally occurring SIV
infections to investigate whether
humans continue to be exposed to SIV
and if such exposure could lead to
additional zoonotic transmissions.
William Hueston (University of
Minnesota, St. Paul, MN) gave a per-
sonal account of how bovine spongi-
form encephalopathy (BSE), appeared
in Europe and how chronic wasting
disease (CWD,—another transmissi-
ble spon-giform encephalopathy that
affects elk and deer) is spreading
across North America. The disease
seriously affects the elk industry.
CWD causes emaciation and eventu-
ally death. The disease has been
endemic for decades in elk and wild
deer populations in southeastern Wyo-
ming, northeastern Colorado, and a
small part of Nebraska. That infec-
tions on elk farms could spread the
disease to wild populations of elk and
deer is of concern and may affect the
hunting industry, especially in eastern
states, which have large populations of
white-tailed deer.
Bioweapons
Edward Eitzen (U.S. Army Medi-
cal Research Institute of Infectious
Diseases [USAMRIID] Fort Detrick,
MD) recounted the history of state-
sponsored biological weapons pro-
grams and the emergence of bioterror-
ism by non-state participants in recent
years. The various ways biological
agents can be used as weapons and the
potential routes of exposure were dis-
cussed as prelude to the medical
effects of these agents and their effects
on the health-care system. Medical
countermeasures and other important
responses to attacks with biological
agents were highlighted, including pri-
orities for the nation to be better pre-
pared.  After the anthrax attacks in
Florida, New York, New Jersey, and
Washington, DC, the threat of biologi-
cal warfare became much more real;
however, these attacks were not the




At the International Conference on
Emerging Infectious Diseases 2002,
held in Atlanta, the Centers for Dis-
ease Control and Prevention (CDC)
released a document entitled, “Pro-
tecting the Nation’s Health in an Era
of Globalization: CDC’s Global Infec-
tious Disease Strategy,” which
describes plans for controlling infec-
tious diseases worldwide. The docu-
ment outlines global partnerships and
measures for improving capacity for
disease surveillance and outbreak
response and for applying proven pub-
lic health tools to the control of
emerging infectious diseases over the
next decade. In addition, the docu-
ment calls for strengthening global
initiatives for disease control, con-
ducting applied research on diseases
of international importance, and build-
ing public health training and capacity
worldwide. 
International Emerging Infections
Programs in various parts of the world
will support the activities outlined in
the global strategy document. The
International Emerging Infections Pro-
gram (IEIP), Thailand, is the first site
in the network of IEIPs proposed in the
plan. Through the IEIP network, mod-
eled after the U.S. Emerging Infections
Program, specialists will work with
local ministries of health to support
laboratory-enhanced, population-based
surveillance for infectious diseases.
Data from this surveillance will allow
ministries of health to prioritize dis-
eases, evaluate targeted interventions,
and support global efforts to prevent
and control disease. IEIPs will train
local scientists and CDC personnel,
provide diagnostic and epidemiologic
resources when outbreaks occur, and
serve as platforms for regional infec-
tious disease control activities. 
In December 2001, IEIP Thailand
and the Southeast Asia Regional Office
of the World Health Organization
hosted a training course on anthrax,
attended by 64 participants from 16
countries. In 2002, IEIP Thailand initi-
ated an investigation of an increase in
reported leptospirosis cases through a
study of hospitalized patients with
febrile illness. IEIP Thailand is plan-
ning studies of respiratory illness and
encephalitis later this year; a second
IEIP site will be launched soon. 
The Global Infectious Disease
Strategy document is available at http:/
/www.cdc.gov/globalidplan. Supple-
mentary materials are available at
http://www.cdc.gov/ncidod. For a print
copy of the strategy, send a request by
e-mail to ncid@cdc.gov; or by fax to
404-639-4194; or contact NCID,
Office of Health Communications,
1600 Clifton Road, NE, Mailstop C14,
Atlanta, GA 30333 USA.
Eric D. Mintz